Literature DB >> 4948308

Long-term tolbutamide treatment after myocardial infarction. A clinical and biochemical study of 178 patients without overt diabetes.

J Paasikivi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4948308

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


× No keyword cloud information.
  13 in total

Review 1.  Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?

Authors:  J J Meier; B Gallwitz; W E Schmidt; A Mügge; M A Nauck
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

2.  Effects of chronic metoprolol treatment on glucose tolerance after myocardial infarction.

Authors:  G Olsson; N Rehnqvist
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 3.  Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Stowers; L J Borthwick
Journal:  Drugs       Date:  1977-07       Impact factor: 9.546

Review 4.  Insulin and oral hypoglycaemic agents. II. Clinical and therapeutic aspects.

Authors:  H D Breidahl; G C Ennis; F I Martin; J R Stawell; P Taft
Journal:  Drugs       Date:  1972       Impact factor: 9.546

5.  [Oral hypoglycaemic agents and cardiovascular deaths in diabetes].

Authors:  M I Drury; F J Timoney
Journal:  Acta Diabetol Lat       Date:  1972 Jul-Aug

6.  Is the use of sulphonylurea derivatives in the treatment of diabetes mellitus dangerous?

Authors:  G R Constam
Journal:  Diabetologia       Date:  1971-08       Impact factor: 10.122

7.  The effects of gliclazide in diabetes: a comparison with tolbutamide.

Authors:  M J Berber; G H Tomkin
Journal:  Ir J Med Sci       Date:  1982-02       Impact factor: 1.568

Review 8.  Defective oxidation of drugs: pharmacokinetic and therapeutic implications.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

Review 9.  Misunderstanding or error? The UGDP report after four years.

Authors:  S Marigo; L Adezati; P Burnetti; G Pozza; L Robba; G Urbinati
Journal:  Acta Diabetol Lat       Date:  1974 Sep-Oct

Review 10.  Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?

Authors:  A Marble
Journal:  Drugs       Date:  1971       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.